tiprankstipranks
Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval
Company Announcements

Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval

Don't Miss Our Christmas Offers:

Renalytix AI (RNLX) just unveiled an announcement.

Renalytix plc announced a significant milestone as Medicare issued its final coverage determination for the company’s innovative product, kidneyintelX.dkd. This breakthrough could impact investors and market-watchers, highlighting a potential growth avenue for Renalytix amidst the healthcare sector’s evolving landscape.

See more data about RNLX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyThree new option listings and two option delistings on October 8th
TheFlyRenalytix commences trading on OTCQB in U.S.
TheFlyRenalytix announces collaboration with Steno Diabetes Center
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App